A large prospective study in Taiwan also found HLA-B*15:02 screening prior to the initiation of CBZ therapy to be successful in preventing CBZ-induced SJS/TEN (Chen et al., 2011). The gene discussed is HLA-B; the disease is toxic epidermal necrolysis.